Skip to content

Co-Diagnostics, Inc.: 10-Q filed 2022-11-10

What Co-Diagnostics, Inc. reported in its quarterly report filed 2022-11-10 (fiscal Q3 2022): 48 published measures, 132 facts as tagged in accession 0001493152-22-031350.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-10
Fiscal period
fiscal Q3 2022
Accession
0001493152-22-031350 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Co-Diagnostics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-30147,841,111USD
At 2021-12-31160,034,282USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-3012,895,694USD
At 2021-12-3125,559,184USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-30134,945,417USD
At 2022-06-30144,470,940USD
At 2022-03-31147,714,792USD
At 2021-12-31134,475,098USD
At 2021-09-30100,158,354USD
At 2021-06-3087,265,943USD
At 2021-03-3176,257,476USD
At 2020-12-3166,696,509USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-3081,507,983USD
At 2021-12-3188,607,234USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,361,062USD92
2022-01-01 to 2022-09-307,667,231USD273
2022-04-01 to 2022-06-30-2,686,303USD91
2022-01-01 to 2022-03-3111,714,596USD90
2021-07-01 to 2021-09-3011,475,966USD92
2021-01-01 to 2021-09-3029,160,154USD273
2021-04-01 to 2021-06-309,785,213USD91
2021-01-01 to 2021-03-317,898,975USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-3010,578,544USD273
2021-01-01 to 2021-09-3036,202,945USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-301,134,208USD273
2021-01-01 to 2021-09-30547,708USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-07-01 to 2022-09-305,094,456USD92
2022-01-01 to 2022-09-3032,816,726USD273
2021-07-01 to 2021-09-3030,101,353USD92
2021-01-01 to 2021-09-3077,484,262USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-12,816,503USD273
2021-01-01 to 2021-09-30450,398USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-4,861,292USD273
2021-01-01 to 2021-09-303,028,192USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-3061,836,510USD
At 2021-12-3154,169,279USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3031,321,368shares92
2022-01-01 to 2022-09-3032,109,213shares273
2021-07-01 to 2021-09-3028,941,357shares92
2021-01-01 to 2021-09-3028,800,450shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-07-01 to 2022-09-3031,321,368shares92
2022-01-01 to 2022-09-3033,002,539shares273
2021-07-01 to 2021-09-3029,952,690shares92
2021-01-01 to 2021-09-3029,872,415shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.04USD/shares92
2022-01-01 to 2022-09-300.24USD/shares273
2021-07-01 to 2021-09-300.4USD/shares92
2021-01-01 to 2021-09-301.01USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.04USD/shares92
2022-01-01 to 2022-09-300.23USD/shares273
2021-07-01 to 2021-09-300.38USD/shares92
2021-01-01 to 2021-09-300.98USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-2,114,638USD92
2022-01-01 to 2022-09-30-1,470,058USD273
2021-07-01 to 2021-09-302,100,594USD92
2021-01-01 to 2021-09-306,231,310USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-302,438,112USD
At 2021-12-311,933,216USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-305,138,815USD273
2021-01-01 to 2021-09-303,851,293USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-6,535,615USD92
2022-01-01 to 2022-09-30-858,493USD273
2021-07-01 to 2021-09-3013,630,121USD92
2021-01-01 to 2021-09-3035,756,187USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-30101,915,715USD
At 2021-12-31115,119,295USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-306,012,209USD
At 2021-12-3112,597,550USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-302,055,889USD
At 2021-12-31607,506USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2022-09-3015,388,546USD
At 2021-12-3114,706,818USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-307,961,664USD
At 2021-12-3120,839,182USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2022-01-01 to 2022-09-3012,994,373USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-3010,862,135USD92
2022-01-01 to 2022-09-3028,709,900USD273
2021-07-01 to 2021-09-3013,159,977USD92
2021-01-01 to 2021-09-3032,639,900USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-09-305,441,726USD
At 2021-12-312,004,169USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-304,326,520USD92
2022-01-01 to 2022-09-3027,851,407USD273
2021-07-01 to 2021-09-3026,790,098USD92
2021-01-01 to 2021-09-3068,396,087USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-07-01 to 2022-09-30767,936USD92
2022-01-01 to 2022-09-304,965,319USD273
2021-07-01 to 2021-09-303,311,255USD92
2021-01-01 to 2021-09-309,088,175USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-305,037,461USD92
2022-01-01 to 2022-09-3012,698,632USD273
2021-07-01 to 2021-09-305,893,350USD92
2021-01-01 to 2021-09-3012,779,573USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3030,917,856shares
At 2021-12-3133,819,862shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-3086,068,948USD
At 2021-12-3180,271,999USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-30456,251USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-30418,816USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-09-3026,875,000USD
At 2021-12-3127,195,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-301,511,720USD
At 2021-12-313,859,652USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-301,241,143USD
At 2021-12-312,338,444USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2021-12-31150,000USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2022-09-303,797,158USD
At 2021-12-317,228,444USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-3,475,700USD92
2022-01-01 to 2022-09-306,197,173USD273
2021-07-01 to 2021-09-3013,576,560USD92
2021-01-01 to 2021-09-3035,391,464USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-303,622,273USD92
2022-01-01 to 2022-09-309,012,888USD273
2021-07-01 to 2021-09-302,919,498USD92
2021-01-01 to 2021-09-308,323,620USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-09-30984,100USD273
2021-01-01 to 2021-09-30232,757USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-07-01 to 2022-09-303,059,915USD92
2022-01-01 to 2022-09-307,055,666USD273
2021-07-01 to 2021-09-30-53,561USD92
2021-01-01 to 2021-09-30-364,723USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-3,431,286USD273
2021-01-01 to 2021-09-3034,672USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-09-304,496,239USD273
2021-01-01 to 2021-09-304,733,200USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-07-01 to 2022-09-30192,659USD92
2022-01-01 to 2022-09-30514,009USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-12,539,461USD273
2021-01-01 to 2021-09-302,608,777USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-303,656,463USD273
2021-01-01 to 2021-09-30-4,432,048USD273

Inspect the source

Entity
Co-Diagnostics, Inc. / CIK 0001692415
Captured
2026-09-21T17:25:24.267Z
SEC response SHA-256
0d45d960bb3fa5de76e632ce55df49625cdea1eb0d33ba7dcda1318f7d31930a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001692415.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))